Clin2
NCT05667246Possibly a fitEnrolling by invitation

Caffeine and oral terbinafine for toenail fungus

Terbinafine Adverse Reaction

Part of Skin clinical trials.

This trial studies how drinking caffeine affects people who are starting oral terbinafine for toenail fungus. It may help explain whether caffeine changes side effects or effectiveness while you take the medicine.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
52 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • Be at least 18 years old
  • You have been diagnosed with toenail fungus (onychomycosis)
  • You are planning to start oral terbinafine soon
  • You are not pregnant and not breastfeeding
  • You do not have a history of anxiety or high blood pressure
  • You are able to understand the study and give consent

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07382427Not yet recruiting· Phase 2
Topical terbinafine for toenail fungus

This study tests a topical antifungal cream (terbinafine) for mild to moderate toenail fungus. It is designed for people who have a fungal infection in one or more toenails but are otherwise healthy.

NCT07152327Not yet recruiting
Terbinafine for fungal ear infection

This trial tests if terbinafine, an antifungal medicine, works for treating fungal infections of the ear (called otomycosis). The study will give the medicine to adults who have been diagnosed with a fungal ear infection to see if it helps clear up symptoms like itching, discharge, or debris in the ear canal.

NCT07046988Recruiting
Terbinafine study for kids with scalp ringworm

This study looks at how the antifungal drug terbinafine works in children aged 2 to 18 who have tinea capitis (scalp ringworm). It aims to find the right dose to treat the infection effectively.

Beijing
NCT06327295Recruiting· Phase 2
Testing a new treatment for mild to moderate toenail fungus

This trial tests an investigational medication called ATB1651 for people with toenail fungus (onychomycosis). If you have a fungal infection covering 20% to 60% of one or both big toenails and are in generally good health, you may be able to join.

Christchurch
NCT06689852Recruiting
Study of two treatments for nail fungus

This trial tests two different treatments for fungus that affects the fingernails or toenails. It is designed to see how well the treatments work and if they are safe.

Villeurbanne, France
NCT06971341Not yet recruiting
Study of Mycoclear and Ciclopirox for nail fungus

This trial tests a combination treatment for toenail fungus (onychomycosis). It uses a special device (Mycoclear) and a medicated nail polish (Ciclopirox). It may help if you have mild to moderate fungus on your big toenail.

Bologna, BO

Hear when a new Terbinafine Adverse Reaction trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.